申请人:Beacon Laboratories, Inc.
公开号:EP1216984A1
公开(公告)日:2002-06-26
Novel acetyloxymethyl esters having the formula (1):
wherein R is as defined in the description, are disclosed. Use of these compounds in treating an illness, including cancer, hemological disorders and inherited metabolic disorders, and treating or ameliorating other conditions using these compounds are also disclosed. The compounds are effective in the inhibition of histone deacetylase.
本发明公开了具有以下式子(1)的新型乙酰氧甲基酯化合物:其中R如描述中定义。本发明还公开了使用这些化合物治疗疾病,包括癌症、血液疾病和遗传代谢疾病,并使用这些化合物治疗或改善其他病症的方法。这些化合物对组蛋白去乙酰化酶的抑制具有有效性。